<DOC>
	<DOCNO>NCT00135109</DOCNO>
	<brief_summary>This phase 3 trial conduct approximately 80 site United States ( U.S. ) investigate whether lacosamide ( SPM 927 ) different dos reduces pain subject diabetic neuropathy . Approximately 455 subject randomize placebo one three dos lacosamide . To qualify trial , subject symptom painful distal diabetic neuropathy range duration 6 month 5 year must average pain intensity great equal 4 11-point Likert scale ( 0-10 scale ) 7 day period prior start treatment . To determine effect lacosamide diabetic neuropathic pain , subject use diary record daily pain intensity ( morning evening ; pain interference sleep ( morning ) activity ( even ) . Use rescue medication ( acetaminophen ) subject ' quality life investigate . In addition , safety tolerability different dos lacosamide investigate .</brief_summary>
	<brief_title>Trial Assess Efficacy Safety SPM 927 ( 200 , 400 , 600mg/Day ) Subjects With Painful Distal Diabetic Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Diabetic neuropathy Subject previously participate trial subject previously assign treatment trial drug investigation trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>